Unfortunately, like other GLP1R agonists, retatrutide also produced significant GI side effects in a large proportion of participants (35% in the 36 week study and 45% in the 48 week study at the 12 mg dose) (Rosenstock et al., 2023)
Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030
Its about designing benefits that are clinically appropriate, financially sustainable and transparent for everyone involved. About the survey The Navitus Health Solutions Pulse Survey questioned 2,000 U.S
Common side effects include: Nausea Vomiting Diarrhea Constipation Bloating Stomach discomfort Indigestion These side effects are typically most noticeable when treatment begins or when doses are increased
After this time, the color of solution became blood red, and distilled water (200 ml) was added